Pediatric calfactant in acute respiratory distress syndrome trial.
about
Rationale for Prolonged Glucocorticoid Use in Pediatric ARDS: What the Adults Can Teach UsRelevant Outcomes in Pediatric Acute Respiratory Distress Syndrome StudiesSurfactant Administration During Pediatric Extracorporeal Membrane OxygenationRegulation of inflammatory biomarkers by intravenous methylprednisolone in pediatric ARDS patients: Results from a double-blind, placebo-controlled randomized pilot trial.Factors associated with interhospital transfer of children with respiratory failure from level II to level I pediatric intensive care units.A Critical Care and Transplantation-Based Approach to Acute Respiratory Failure after Hematopoietic Stem Cell Transplantation in Children.Adjunctive treatments in pediatric acute respiratory distress syndrome.Pulse oximetry vs. PaO2 metrics in mechanically ventilated children: Berlin definition of ARDS and mortality risk.Surfactants in Acute Respiratory Distress Syndrome in Infants and Children: Past, Present and Future.Mortality in Pediatric Acute Respiratory Distress Syndrome: A Systematic Review and Meta-Analysis.Surfactant protein C peptides with salt-bridges ("ion-locks") promote high surfactant activities by mimicking the α-helix and membrane topography of the native proteinVariability in Usual Care Mechanical Ventilation for Pediatric Acute Respiratory Distress Syndrome: Time for a Decision Support Protocol?Did Reduced Alveolar Delivery of Surfactant Contribute to Negative Results in Adults with Acute Respiratory Distress Syndrome?Potential Acceptability of a Pediatric Ventilator Management Computer Protocol.Paediatric ventilation treatment of acute lung injury in Nordic intensive care units.Hyperoxia treatment of TREK-1/TREK-2/TRAAK-deficient mice is associated with a reduction in surfactant proteins.Multiple Organ Dysfunction in Children Mechanically Ventilated for Acute Respiratory Failure.Exogenous surfactant and alveolar recruitment in the treatment of the acute respiratory distress syndrome.
P2860
Q26744478-D620570B-3D84-4E04-B400-615FC2BA4B0EQ26744504-9E0462A5-4B32-4269-B2C1-6E04714EBAC9Q36244883-4BDB6DD4-6CC6-471F-A285-3220B2FE460FQ36338911-D80D674E-10EB-45E3-BDF5-541AD87C0A2DQ36378379-4AACBED6-D5B9-4634-90BC-6F3A924A22ABQ37276584-E7292DAB-0C6C-484B-8CEE-C95F6DD852B5Q38239584-09B4D944-A44F-4F3F-936E-90FF61D07BAEQ38250781-7C1038A5-504F-4FAC-8A19-494BA4149BEFQ38683183-6077281E-76EA-424A-BC53-F87CA99F6F0EQ38810730-7E172575-30A0-4173-97B4-D358C27F900CQ42742507-1073C488-087B-4897-A1F0-69658BFFCEE2Q44645184-B8F691A4-5A30-4F19-A6D0-16477511372BQ45052745-82DEF999-2808-4516-9CC5-5980BEAB14E8Q46667354-480F3DDA-2ADB-40E8-B4AE-8DCC52644A8AQ47737341-D8943E21-D93C-45FE-BF05-A4FB23EBD605Q47793284-01148DF0-21A2-4FB8-8759-B82401EBE946Q47971534-9D712234-DCF6-4252-A9D3-E454C0A2271AQ51546759-BFD49360-0453-4BF0-92C8-D8875C11DE86
P2860
Pediatric calfactant in acute respiratory distress syndrome trial.
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Pediatric calfactant in acute respiratory distress syndrome trial.
@ast
Pediatric calfactant in acute respiratory distress syndrome trial.
@en
type
label
Pediatric calfactant in acute respiratory distress syndrome trial.
@ast
Pediatric calfactant in acute respiratory distress syndrome trial.
@en
prefLabel
Pediatric calfactant in acute respiratory distress syndrome trial.
@ast
Pediatric calfactant in acute respiratory distress syndrome trial.
@en
P2093
P1476
Pediatric calfactant in acute respiratory distress syndrome trial.
@en
P2093
Christine Traul
Douglas F Willson
Edmund E Egan
Edward Truemper
Jonathon Truwit
Mark Conaway
Pediatric Acute Lung and Sepsis Investigators Network
Robert Tamburro
P304
P356
10.1097/PCC.0B013E3182917B68
P50
P577
2013-09-01T00:00:00Z